Check out the Detailed Program! Learn More

Esophageal Lichen Planus: Diagnosis and Management

Esophageal lichen planus is an uncommon inflammatory disorder that can cause progressive swallowing difficulty, food impaction, mucosal fragility, and esophageal narrowing. It is usually associated with lichen planus affecting the mouth, skin, scalp, nails, or genital mucosa, although esophageal disease may occasionally be the first recognized manifestation.

Because symptoms can resemble reflux, eosinophilic esophagitis, infection, or malignancy, diagnosis requires careful endoscopic assessment and targeted biopsies. Early recognition matters: untreated inflammation may lead to strictures and repeated procedures, while chronic mucosal injury may require individualized cancer surveillance.

Understanding The Disease

Lichen planus is an immune-mediated condition in which T-cell inflammation targets epithelial tissues. In the esophagus, this process can produce mucosal sloughing, erosions, white lacy markings, friability, and scarring. The upper and middle esophagus are commonly involved, although any segment may be affected.

The condition is reported most often in middle-aged women with oral or cutaneous lichen planus. Dysphagia is the leading symptom, followed by odynophagia, chest discomfort, regurgitation, and weight loss. Symptoms may progress gradually, so a patient’s changing diet or recurrent food impaction should not be dismissed as routine reflux.

Recognizing Clinical Patterns

A detailed history should cover the speed of symptom progression, episodes of food obstruction, painful swallowing, reflux treatment, medication exposure, and prior endoscopic findings. Examination of the mouth, tongue, gums, scalp, nails, and genital skin can reveal subtle lesions that support the diagnosis.

Endoscopy may show white papules or reticular streaks, mucosal denudation, longitudinal furrows, erosions, bleeding with light contact, and proximal strictures. The mucosa may appear deceptively normal between active areas. Careful inspection is important because forceful instrumentation can worsen tissue injury.

Confirming The Diagnosis

Several biopsies should be obtained from abnormal areas and, when appropriate, from apparently unaffected mucosa. Histology may demonstrate a lichenoid lymphocytic infiltrate, basal cell degeneration, apoptotic keratinocytes, hypergranulosis, and subepithelial separation. Findings can be patchy, and superficial samples may fail to capture diagnostic changes.

Direct immunofluorescence may help distinguish lichen planus from autoimmune blistering disorders, but results are not always definitive. The diagnosis should combine clinical findings, endoscopic appearance, pathology, and evidence of lichen planus elsewhere on the body. Dermatology, gastroenterology, and pathology collaboration is particularly valuable in uncertain cases.

Condition Helpful Clues Key Diagnostic Consideration
Esophageal lichen planus Oral or skin lesions, proximal disease, fragile mucosa, strictures Multiple biopsies and clinical correlation
Eosinophilic esophagitis Atopy, rings, furrows, food impaction Esophageal eosinophil density on biopsies
Esophageal pemphigoid or pemphigus Blistering, extensive mucosal involvement Immunofluorescence and serum testing
Candida esophagitis Odynophagia, immunosuppression, adherent plaques Fungal elements on brushings or biopsy
Reflux esophagitis Heartburn, distal predominant inflammation Response to acid suppression does not prove LP
Esophageal cancer Progressive dysphagia, weight loss, focal mass or ulcer Deep, targeted biopsy and staging

Selecting Medical Treatment

There is no universally accepted treatment algorithm, so therapy should reflect disease severity, stricture formation, comorbidities, and involvement of other organs. A swallowed topical corticosteroid, such as budesonide or fluticasone, is commonly used to deliver anti-inflammatory medication directly to the esophagus. Patients need clear instructions on administration and should avoid eating or drinking for a period afterward according to the prescribing clinician’s directions.

Systemic corticosteroids may be considered for severe, rapidly progressive, or extensive disease. Steroid-sparing medicines, including mycophenolate mofetil, azathioprine, methotrexate, or other immunomodulators, have been used when symptoms persist or steroid exposure becomes problematic. Evidence is based largely on case series and specialist experience, so treatment should be supervised by clinicians familiar with immune-mediated esophageal disease.

Acid suppression may protect against coexisting gastroesophageal reflux and support mucosal healing, but it does not treat the underlying lichenoid inflammation. Oral, genital, ocular, or skin disease should be managed at the same time, with referrals to dermatology, oral medicine, gynecology, or ophthalmology when indicated.

Managing Strictures And Complications

Fibrotic narrowing can make swallowing difficult even after active inflammation improves. Endoscopic dilation may restore the esophageal lumen, but it should be performed cautiously because inflamed, fragile tissue carries a higher risk of tearing or perforation. Gradual dilation, experienced operators, and ongoing anti-inflammatory treatment can reduce complications and recurrence.

Patients should receive urgent assessment for complete food impaction, inability to swallow liquids, vomiting blood, severe chest pain, or signs of perforation. Nutritional review is useful when a restricted diet, weight loss, or repeated procedures affect intake. Recurrent strictures often require coordinated planning rather than dilation alone.

Planning Long-Term Follow-Up

Symptoms, nutritional status, endoscopic appearance, and treatment toxicity should be reviewed regularly. Repeat endoscopy is guided by symptoms, persistent narrowing, inadequate treatment response, or concern for dysplasia. Any new focal ulcer, mass, unexplained bleeding, or sudden change in swallowing requires prompt investigation.

Chronic esophageal inflammation has been associated with an increased risk of esophageal squamous cell carcinoma, although the absolute risk and ideal surveillance interval remain uncertain. Clinicians should document risk factors, biopsy suspicious lesions, and individualize surveillance rather than applying a rigid schedule to every patient.

Practical Clinical Priorities

  • Inspect for oral, cutaneous, nail, scalp, and genital signs of lichen planus.
  • Obtain multiple biopsies and request clinicopathologic correlation.
  • Treat active inflammation before, during, and after management of strictures.
  • Use swallowed corticosteroids or systemic immunosuppression under specialist supervision.
  • Investigate new focal lesions, progressive dysphagia, bleeding, or unexplained weight loss promptly.

Education from specialist meetings and esophageal disease research can support consistent recognition of this rare disorder. Clinicians caring for patients with persistent dysphagia or mucosal lichen planus should include esophageal involvement in the differential diagnosis and arrange coordinated evaluation before complications become established.

About ISDE

The ISDE is an international, multispecialty society devoted to the study of the esophagus in disease and in health that was founded in 1979. The aims of the ISDE are to promote the exchange of scientific and medical knowledge among specialists in the field, to maintain interchange with organizations and industries, and to encourage basic and clinical research in fields related to the esophagus. In order to promote the professional and educational development of individuals interested in the esophagus, the ISDE sponsors its own journal, international congresses, and other educational programs. The ISDE Secretariat was in Tokyo, Japan, from 1979 to 2004, and then resided in Los Angeles, California, from 2004 through 2010. Since 2010 the Secretariat has been in Vancouver, British Columbia, under the auspices of International Conferences Service, Ltd. The ISDE welcomes participation by existing members and encourages individuals who are professionally interested in the esophagus to become members. Benefits include reduced registration fees at our congresses and other educational offerings, restricted access to website content and member search capability, access to webcasts, reduced subscription rates for our journal, and the opportunity to help lead this organization into a position of leadership in the worldwide medical community.